Showing results (2061-2070 of 2,085) with videos related to
Sort By:
Pageof 209
Chinese Medical Journal|October 16, 2020
Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasisLin Cai, Jian-Zhong Zhang, Xu Yao, et al.Journal of Orthopaedic Translation|October 25, 2021
General recommendation for assessment and management on the risk of glucocorticoid-induced osteonecrosis in patients with COVID-19Wenlong Li, Zeqing Huang, Biao Tan, et al.Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Painting blood vessels and atherosclerotic plaques with an adhesive drug depotChristian J Kastrup, Matthias Nahrendorf, Jose Luiz Figueiredo, et al.The British Journal of Dermatology|November 29, 2025
Ivarmacitinib ointment for the treatment of adults with mild-to-moderate atopic dermatitis: phase 3 part of a randomized, double-blind, placebo-controlled, phase 2/3 clinical trialDuoqin Wang, Jiyuan Wu, Qing Guo, et al.Brain : a Journal of Neurology|April 4, 2017
A recurrent WARS mutation is a novel cause of autosomal dominant distal hereditary motor neuropathyPei-Chien Tsai, Bing-Wen Soong, Inès Mademan, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|July 1, 2024
Efficacy and safety of topical minocycline foam (FMX101 4%) in treatment of Chinese subjects with moderate-to-severe facial acne vulgaris: A phase 3, multi-centre, randomized, double-blind, vehicle-controlled studyYan Le, Wenlin Yang, Jianyun Lu, et al.Lung Cancer (Amsterdam, Netherlands)|April 22, 2008
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapyReury-Perng Perng, Chih-Hsin Yang, Yuh-Min Chen, et al.Nature Medicine|June 26, 2026
Evaluating the robustness and readiness of large frontier models in health AI applicationsYu Gu, Jingjing Fu, Xiaodong Liu, et al.The Journal of Dermatological Treatment|July 15, 2026
Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trialsYan Zhao, Furen Zhang, Bin Yang, et al.Chinese Medical Journal|September 8, 2025
Efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled trialKun Huang, Songmei Geng, Xiaohua Tao, et al.Pageof 209